nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—HTR2B—Sorafenib—thyroid cancer	0.377	0.606	CbGbCtD
Apomorphine—HTR2C—Sorafenib—thyroid cancer	0.245	0.394	CbGbCtD
Apomorphine—Rhinorrhoea—Sorafenib—thyroid cancer	0.00791	0.036	CcSEcCtD
Apomorphine—Dehydration—Vandetanib—thyroid cancer	0.00641	0.0292	CcSEcCtD
Apomorphine—Nasopharyngitis—Vandetanib—thyroid cancer	0.00616	0.0281	CcSEcCtD
Apomorphine—Pneumonia—Vandetanib—thyroid cancer	0.00534	0.0244	CcSEcCtD
Apomorphine—Urinary tract infection—Vandetanib—thyroid cancer	0.00516	0.0235	CcSEcCtD
Apomorphine—Cardiac failure congestive—Sorafenib—thyroid cancer	0.00513	0.0234	CcSEcCtD
Apomorphine—Pain in extremity—Sorafenib—thyroid cancer	0.00465	0.0212	CcSEcCtD
Apomorphine—Dehydration—Sorafenib—thyroid cancer	0.00432	0.0197	CcSEcCtD
Apomorphine—Mental disorder—Vandetanib—thyroid cancer	0.00418	0.019	CcSEcCtD
Apomorphine—Nasopharyngitis—Sorafenib—thyroid cancer	0.00416	0.019	CcSEcCtD
Apomorphine—Loss of consciousness—Vandetanib—thyroid cancer	0.00365	0.0166	CcSEcCtD
Apomorphine—Pneumonia—Sorafenib—thyroid cancer	0.0036	0.0164	CcSEcCtD
Apomorphine—Arthralgia—Vandetanib—thyroid cancer	0.00353	0.0161	CcSEcCtD
Apomorphine—Chest pain—Vandetanib—thyroid cancer	0.00353	0.0161	CcSEcCtD
Apomorphine—Anxiety—Vandetanib—thyroid cancer	0.00352	0.0161	CcSEcCtD
Apomorphine—Oedema—Vandetanib—thyroid cancer	0.00339	0.0154	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00309	0.0141	CcSEcCtD
Apomorphine—Insomnia—Vandetanib—thyroid cancer	0.00306	0.014	CcSEcCtD
Apomorphine—Dyspnoea—Vandetanib—thyroid cancer	0.00302	0.0138	CcSEcCtD
Apomorphine—Flushing—Sorafenib—thyroid cancer	0.00299	0.0136	CcSEcCtD
Apomorphine—Fatigue—Vandetanib—thyroid cancer	0.00292	0.0133	CcSEcCtD
Apomorphine—Constipation—Vandetanib—thyroid cancer	0.0029	0.0132	CcSEcCtD
Apomorphine—Mental disorder—Sorafenib—thyroid cancer	0.00282	0.0128	CcSEcCtD
Apomorphine—Dyskinesia—Epirubicin—thyroid cancer	0.00252	0.0115	CcSEcCtD
Apomorphine—Syncope—Sorafenib—thyroid cancer	0.00251	0.0114	CcSEcCtD
Apomorphine—Loss of consciousness—Sorafenib—thyroid cancer	0.00246	0.0112	CcSEcCtD
Apomorphine—Asthenia—Vandetanib—thyroid cancer	0.00243	0.0111	CcSEcCtD
Apomorphine—Pruritus—Vandetanib—thyroid cancer	0.0024	0.0109	CcSEcCtD
Apomorphine—Arthralgia—Sorafenib—thyroid cancer	0.00238	0.0109	CcSEcCtD
Apomorphine—Injection site reaction—Epirubicin—thyroid cancer	0.00235	0.0107	CcSEcCtD
Apomorphine—Dyskinesia—Doxorubicin—thyroid cancer	0.00233	0.0106	CcSEcCtD
Apomorphine—Diarrhoea—Vandetanib—thyroid cancer	0.00232	0.0106	CcSEcCtD
Apomorphine—Shock—Sorafenib—thyroid cancer	0.00225	0.0102	CcSEcCtD
Apomorphine—Dizziness—Vandetanib—thyroid cancer	0.00224	0.0102	CcSEcCtD
Apomorphine—Injection site reaction—Doxorubicin—thyroid cancer	0.00218	0.00993	CcSEcCtD
Apomorphine—Vomiting—Vandetanib—thyroid cancer	0.00215	0.00982	CcSEcCtD
Apomorphine—Ecchymosis—Epirubicin—thyroid cancer	0.00214	0.00976	CcSEcCtD
Apomorphine—Headache—Vandetanib—thyroid cancer	0.00212	0.00967	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00208	0.00949	CcSEcCtD
Apomorphine—Dyspnoea—Sorafenib—thyroid cancer	0.00204	0.00929	CcSEcCtD
Apomorphine—Nausea—Vandetanib—thyroid cancer	0.00201	0.00917	CcSEcCtD
Apomorphine—Ecchymosis—Doxorubicin—thyroid cancer	0.00198	0.00903	CcSEcCtD
Apomorphine—Fatigue—Sorafenib—thyroid cancer	0.00197	0.00898	CcSEcCtD
Apomorphine—Constipation—Sorafenib—thyroid cancer	0.00195	0.00891	CcSEcCtD
Apomorphine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00189	0.00864	CcSEcCtD
Apomorphine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00175	0.00799	CcSEcCtD
Apomorphine—Pain in extremity—Epirubicin—thyroid cancer	0.00172	0.00783	CcSEcCtD
Apomorphine—Asthenia—Sorafenib—thyroid cancer	0.00164	0.00747	CcSEcCtD
Apomorphine—Pruritus—Sorafenib—thyroid cancer	0.00162	0.00737	CcSEcCtD
Apomorphine—Dehydration—Epirubicin—thyroid cancer	0.0016	0.00728	CcSEcCtD
Apomorphine—Pain in extremity—Doxorubicin—thyroid cancer	0.00159	0.00725	CcSEcCtD
Apomorphine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00157	0.00715	CcSEcCtD
Apomorphine—Diarrhoea—Sorafenib—thyroid cancer	0.00156	0.00713	CcSEcCtD
Apomorphine—Nasopharyngitis—Epirubicin—thyroid cancer	0.00154	0.007	CcSEcCtD
Apomorphine—Dizziness—Sorafenib—thyroid cancer	0.00151	0.00689	CcSEcCtD
Apomorphine—Dehydration—Doxorubicin—thyroid cancer	0.00148	0.00674	CcSEcCtD
Apomorphine—Vomiting—Sorafenib—thyroid cancer	0.00145	0.00662	CcSEcCtD
Apomorphine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00145	0.00662	CcSEcCtD
Apomorphine—Angina pectoris—Epirubicin—thyroid cancer	0.00145	0.00659	CcSEcCtD
Apomorphine—Headache—Sorafenib—thyroid cancer	0.00143	0.00653	CcSEcCtD
Apomorphine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00142	0.00648	CcSEcCtD
Apomorphine—Nausea—Sorafenib—thyroid cancer	0.00136	0.00619	CcSEcCtD
Apomorphine—Angina pectoris—Doxorubicin—thyroid cancer	0.00134	0.0061	CcSEcCtD
Apomorphine—Pneumonia—Epirubicin—thyroid cancer	0.00133	0.00607	CcSEcCtD
Apomorphine—Drowsiness—Epirubicin—thyroid cancer	0.00132	0.00604	CcSEcCtD
Apomorphine—Urinary tract infection—Epirubicin—thyroid cancer	0.00129	0.00587	CcSEcCtD
Apomorphine—Pneumonia—Doxorubicin—thyroid cancer	0.00123	0.00562	CcSEcCtD
Apomorphine—Drowsiness—Doxorubicin—thyroid cancer	0.00123	0.00559	CcSEcCtD
Apomorphine—Urinary tract infection—Doxorubicin—thyroid cancer	0.00119	0.00543	CcSEcCtD
Apomorphine—Flushing—Epirubicin—thyroid cancer	0.0011	0.00503	CcSEcCtD
Apomorphine—Mental disorder—Epirubicin—thyroid cancer	0.00104	0.00475	CcSEcCtD
Apomorphine—Flushing—Doxorubicin—thyroid cancer	0.00102	0.00465	CcSEcCtD
Apomorphine—Back pain—Epirubicin—thyroid cancer	0.001	0.00456	CcSEcCtD
Apomorphine—Mental disorder—Doxorubicin—thyroid cancer	0.000964	0.00439	CcSEcCtD
Apomorphine—Syncope—Epirubicin—thyroid cancer	0.000928	0.00423	CcSEcCtD
Apomorphine—Back pain—Doxorubicin—thyroid cancer	0.000926	0.00422	CcSEcCtD
Apomorphine—Loss of consciousness—Epirubicin—thyroid cancer	0.000909	0.00415	CcSEcCtD
Apomorphine—Arthralgia—Epirubicin—thyroid cancer	0.000881	0.00402	CcSEcCtD
Apomorphine—Chest pain—Epirubicin—thyroid cancer	0.000881	0.00402	CcSEcCtD
Apomorphine—Anxiety—Epirubicin—thyroid cancer	0.000878	0.004	CcSEcCtD
Apomorphine—Syncope—Doxorubicin—thyroid cancer	0.000859	0.00391	CcSEcCtD
Apomorphine—Confusional state—Epirubicin—thyroid cancer	0.000852	0.00388	CcSEcCtD
Apomorphine—Oedema—Epirubicin—thyroid cancer	0.000844	0.00385	CcSEcCtD
Apomorphine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000841	0.00384	CcSEcCtD
Apomorphine—Shock—Epirubicin—thyroid cancer	0.000831	0.00379	CcSEcCtD
Apomorphine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000816	0.00372	CcSEcCtD
Apomorphine—Chest pain—Doxorubicin—thyroid cancer	0.000815	0.00372	CcSEcCtD
Apomorphine—Arthralgia—Doxorubicin—thyroid cancer	0.000815	0.00372	CcSEcCtD
Apomorphine—Anxiety—Doxorubicin—thyroid cancer	0.000812	0.0037	CcSEcCtD
Apomorphine—Hypotension—Epirubicin—thyroid cancer	0.000789	0.0036	CcSEcCtD
Apomorphine—Confusional state—Doxorubicin—thyroid cancer	0.000788	0.00359	CcSEcCtD
Apomorphine—Oedema—Doxorubicin—thyroid cancer	0.000781	0.00356	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000769	0.00351	CcSEcCtD
Apomorphine—Shock—Doxorubicin—thyroid cancer	0.000769	0.0035	CcSEcCtD
Apomorphine—Insomnia—Epirubicin—thyroid cancer	0.000764	0.00348	CcSEcCtD
Apomorphine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000755	0.00344	CcSEcCtD
Apomorphine—Dyspnoea—Epirubicin—thyroid cancer	0.000753	0.00343	CcSEcCtD
Apomorphine—CALY—head—thyroid cancer	0.000752	0.12	CbGeAlD
Apomorphine—Somnolence—Epirubicin—thyroid cancer	0.000751	0.00342	CcSEcCtD
Apomorphine—Hypotension—Doxorubicin—thyroid cancer	0.00073	0.00333	CcSEcCtD
Apomorphine—Fatigue—Epirubicin—thyroid cancer	0.000728	0.00332	CcSEcCtD
Apomorphine—Constipation—Epirubicin—thyroid cancer	0.000722	0.00329	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000712	0.00325	CcSEcCtD
Apomorphine—Insomnia—Doxorubicin—thyroid cancer	0.000707	0.00322	CcSEcCtD
Apomorphine—Dyspnoea—Doxorubicin—thyroid cancer	0.000697	0.00318	CcSEcCtD
Apomorphine—Feeling abnormal—Epirubicin—thyroid cancer	0.000696	0.00317	CcSEcCtD
Apomorphine—Somnolence—Doxorubicin—thyroid cancer	0.000695	0.00317	CcSEcCtD
Apomorphine—Fatigue—Doxorubicin—thyroid cancer	0.000674	0.00307	CcSEcCtD
Apomorphine—Constipation—Doxorubicin—thyroid cancer	0.000668	0.00305	CcSEcCtD
Apomorphine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000644	0.00294	CcSEcCtD
Apomorphine—Asthenia—Epirubicin—thyroid cancer	0.000606	0.00276	CcSEcCtD
Apomorphine—Pruritus—Epirubicin—thyroid cancer	0.000597	0.00272	CcSEcCtD
Apomorphine—Diarrhoea—Epirubicin—thyroid cancer	0.000578	0.00263	CcSEcCtD
Apomorphine—Asthenia—Doxorubicin—thyroid cancer	0.000561	0.00256	CcSEcCtD
Apomorphine—Dizziness—Epirubicin—thyroid cancer	0.000558	0.00255	CcSEcCtD
Apomorphine—Pruritus—Doxorubicin—thyroid cancer	0.000553	0.00252	CcSEcCtD
Apomorphine—Vomiting—Epirubicin—thyroid cancer	0.000537	0.00245	CcSEcCtD
Apomorphine—Diarrhoea—Doxorubicin—thyroid cancer	0.000535	0.00244	CcSEcCtD
Apomorphine—Headache—Epirubicin—thyroid cancer	0.000529	0.00241	CcSEcCtD
Apomorphine—CALY—lymph node—thyroid cancer	0.000527	0.0842	CbGeAlD
Apomorphine—Dizziness—Doxorubicin—thyroid cancer	0.000517	0.00236	CcSEcCtD
Apomorphine—Nausea—Epirubicin—thyroid cancer	0.000502	0.00229	CcSEcCtD
Apomorphine—Vomiting—Doxorubicin—thyroid cancer	0.000497	0.00226	CcSEcCtD
Apomorphine—Headache—Doxorubicin—thyroid cancer	0.00049	0.00223	CcSEcCtD
Apomorphine—Nausea—Doxorubicin—thyroid cancer	0.000464	0.00212	CcSEcCtD
Apomorphine—DRD3—head—thyroid cancer	0.000406	0.0649	CbGeAlD
Apomorphine—DRD5—head—thyroid cancer	0.000381	0.0608	CbGeAlD
Apomorphine—ADRA1B—head—thyroid cancer	0.000312	0.0499	CbGeAlD
Apomorphine—ADRA1D—head—thyroid cancer	0.000305	0.0488	CbGeAlD
Apomorphine—DRD1—head—thyroid cancer	0.000291	0.0465	CbGeAlD
Apomorphine—HTR2A—neck—thyroid cancer	0.000268	0.0429	CbGeAlD
Apomorphine—HTR2B—thyroid gland—thyroid cancer	0.000239	0.0382	CbGeAlD
Apomorphine—ADRA2C—trachea—thyroid cancer	0.000238	0.038	CbGeAlD
Apomorphine—HTR1B—head—thyroid cancer	0.000236	0.0377	CbGeAlD
Apomorphine—HTR1D—head—thyroid cancer	0.000228	0.0365	CbGeAlD
Apomorphine—HTR2C—head—thyroid cancer	0.000226	0.0361	CbGeAlD
Apomorphine—HTR2B—head—thyroid cancer	0.000212	0.0339	CbGeAlD
Apomorphine—HTR1A—head—thyroid cancer	0.00019	0.0304	CbGeAlD
Apomorphine—ADRA2A—trachea—thyroid cancer	0.00019	0.0304	CbGeAlD
Apomorphine—DRD2—head—thyroid cancer	0.000172	0.0275	CbGeAlD
Apomorphine—ADRA2C—head—thyroid cancer	0.000167	0.0267	CbGeAlD
Apomorphine—HTR2A—trachea—thyroid cancer	0.000162	0.0258	CbGeAlD
Apomorphine—ADRA2A—thyroid gland—thyroid cancer	0.00015	0.024	CbGeAlD
Apomorphine—HTR2B—lymph node—thyroid cancer	0.000149	0.0237	CbGeAlD
Apomorphine—ADRA2A—head—thyroid cancer	0.000133	0.0213	CbGeAlD
Apomorphine—ADRA2C—lymph node—thyroid cancer	0.000117	0.0187	CbGeAlD
Apomorphine—HTR2A—head—thyroid cancer	0.000113	0.0181	CbGeAlD
Apomorphine—ADRA2A—lymph node—thyroid cancer	9.34e-05	0.0149	CbGeAlD
Apomorphine—DRD3—Signaling Pathways—TERT—thyroid cancer	5.14e-05	0.000337	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—NRAS—thyroid cancer	5.06e-05	0.000331	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NRG1—thyroid cancer	4.99e-05	0.000327	CbGpPWpGaD
Apomorphine—ADRA2B—Hemostasis—HRAS—thyroid cancer	4.99e-05	0.000326	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—HIF1A—thyroid cancer	4.98e-05	0.000326	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NRG1—thyroid cancer	4.97e-05	0.000325	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—NRAS—thyroid cancer	4.96e-05	0.000324	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—HIF1A—thyroid cancer	4.92e-05	0.000322	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—HIF1A—thyroid cancer	4.92e-05	0.000322	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	4.89e-05	0.00032	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—NRAS—thyroid cancer	4.88e-05	0.000319	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—TP53—thyroid cancer	4.87e-05	0.000319	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—HRAS—thyroid cancer	4.83e-05	0.000316	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NRG1—thyroid cancer	4.83e-05	0.000316	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—BRAF—thyroid cancer	4.76e-05	0.000311	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NRG1—thyroid cancer	4.75e-05	0.000311	CbGpPWpGaD
Apomorphine—DRD5—GPCR downstream signaling—AKT1—thyroid cancer	4.7e-05	0.000308	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—BRAF—thyroid cancer	4.66e-05	0.000305	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—HRAS—thyroid cancer	4.66e-05	0.000305	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—NRAS—thyroid cancer	4.66e-05	0.000305	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TERT—thyroid cancer	4.64e-05	0.000304	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—BRAF—thyroid cancer	4.58e-05	0.0003	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—CCND1—thyroid cancer	4.53e-05	0.000297	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TERT—thyroid cancer	4.48e-05	0.000293	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TERT—thyroid cancer	4.46e-05	0.000292	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—KRAS—thyroid cancer	4.45e-05	0.000291	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	4.44e-05	0.000291	CbGpPWpGaD
Apomorphine—ADRA2B—Hemostasis—AKT1—thyroid cancer	4.4e-05	0.000288	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—NRAS—thyroid cancer	4.39e-05	0.000287	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NRG1—thyroid cancer	4.38e-05	0.000287	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—BRAF—thyroid cancer	4.38e-05	0.000286	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—PTEN—thyroid cancer	4.38e-05	0.000286	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—KRAS—thyroid cancer	4.36e-05	0.000285	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TERT—thyroid cancer	4.34e-05	0.000284	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—NRAS—thyroid cancer	4.33e-05	0.000284	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—NRAS—thyroid cancer	4.33e-05	0.000284	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NRG1—thyroid cancer	4.31e-05	0.000282	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	4.29e-05	0.00028	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—AKT1—thyroid cancer	4.27e-05	0.000279	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TERT—thyroid cancer	4.27e-05	0.000279	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—KRAS—thyroid cancer	4.27e-05	0.000279	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	4.26e-05	0.000279	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PPARG—thyroid cancer	4.22e-05	0.000276	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—KRAS—thyroid cancer	4.2e-05	0.000275	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	4.15e-05	0.000271	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—BRAF—thyroid cancer	4.13e-05	0.00027	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—AKT1—thyroid cancer	4.11e-05	0.000269	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	4.08e-05	0.000267	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—BRAF—thyroid cancer	4.07e-05	0.000267	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—BRAF—thyroid cancer	4.07e-05	0.000267	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—KRAS—thyroid cancer	4.01e-05	0.000262	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—TP53—thyroid cancer	3.96e-05	0.000259	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TERT—thyroid cancer	3.93e-05	0.000257	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	3.92e-05	0.000257	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	3.91e-05	0.000256	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—NRAS—thyroid cancer	3.9e-05	0.000255	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TERT—thyroid cancer	3.87e-05	0.000253	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—HRAS—thyroid cancer	3.78e-05	0.000248	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—KRAS—thyroid cancer	3.78e-05	0.000247	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	3.78e-05	0.000247	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—HIF1A—thyroid cancer	3.76e-05	0.000246	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	3.76e-05	0.000246	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—KRAS—thyroid cancer	3.73e-05	0.000244	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—KRAS—thyroid cancer	3.73e-05	0.000244	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	3.7e-05	0.000242	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	3.7e-05	0.000242	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	3.68e-05	0.000241	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	3.65e-05	0.000239	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—HRAS—thyroid cancer	3.63e-05	0.000237	CbGpPWpGaD
Apomorphine—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	3.6e-05	0.000236	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	3.6e-05	0.000235	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—HRAS—thyroid cancer	3.57e-05	0.000234	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—BRAF—thyroid cancer	3.55e-05	0.000232	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—BRAF—thyroid cancer	3.53e-05	0.000231	CbGpPWpGaD
Apomorphine—HTR1B—GPCR downstream signaling—AKT1—thyroid cancer	3.53e-05	0.000231	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	3.52e-05	0.000231	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CCND1—thyroid cancer	3.47e-05	0.000227	CbGpPWpGaD
Apomorphine—DRD4—GPCR downstream signaling—AKT1—thyroid cancer	3.47e-05	0.000227	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	3.43e-05	0.000225	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PPARG—thyroid cancer	3.43e-05	0.000224	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—HRAS—thyroid cancer	3.41e-05	0.000223	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CCND1—thyroid cancer	3.4e-05	0.000223	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	3.38e-05	0.000221	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	3.37e-05	0.00022	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	3.37e-05	0.00022	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—KRAS—thyroid cancer	3.36e-05	0.00022	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—PTEN—thyroid cancer	3.35e-05	0.000219	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CCND1—thyroid cancer	3.35e-05	0.000219	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—AKT1—thyroid cancer	3.34e-05	0.000219	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PTGS2—thyroid cancer	3.32e-05	0.000217	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	3.31e-05	0.000217	CbGpPWpGaD
Apomorphine—HTR2B—GPCR downstream signaling—AKT1—thyroid cancer	3.31e-05	0.000217	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—PTEN—thyroid cancer	3.28e-05	0.000215	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	3.27e-05	0.000214	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	3.26e-05	0.000213	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	3.25e-05	0.000213	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	3.23e-05	0.000212	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—PTEN—thyroid cancer	3.23e-05	0.000211	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—HRAS—thyroid cancer	3.21e-05	0.00021	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—AKT1—thyroid cancer	3.2e-05	0.00021	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CCND1—thyroid cancer	3.19e-05	0.000209	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—HRAS—thyroid cancer	3.17e-05	0.000207	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	3.17e-05	0.000207	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—AKT1—thyroid cancer	3.15e-05	0.000206	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	3.14e-05	0.000206	CbGpPWpGaD
Apomorphine—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	3.12e-05	0.000204	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—BRAF—thyroid cancer	3.12e-05	0.000204	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	3.09e-05	0.000203	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—PTEN—thyroid cancer	3.08e-05	0.000202	CbGpPWpGaD
Apomorphine—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	3.08e-05	0.000202	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	3.08e-05	0.000202	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	3.07e-05	0.000201	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CCND1—thyroid cancer	3.01e-05	0.000197	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—AKT1—thyroid cancer	3.01e-05	0.000197	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—NRAS—thyroid cancer	2.99e-05	0.000196	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—TP53—thyroid cancer	2.99e-05	0.000195	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CCND1—thyroid cancer	2.97e-05	0.000194	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	2.97e-05	0.000194	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	2.97e-05	0.000194	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—NRAS—thyroid cancer	2.93e-05	0.000192	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PTEN—thyroid cancer	2.91e-05	0.00019	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PTEN—thyroid cancer	2.89e-05	0.000189	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—NRAS—thyroid cancer	2.88e-05	0.000189	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PTEN—thyroid cancer	2.87e-05	0.000188	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	2.87e-05	0.000188	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	2.86e-05	0.000187	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—HRAS—thyroid cancer	2.86e-05	0.000187	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	2.85e-05	0.000187	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—AKT1—thyroid cancer	2.84e-05	0.000186	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	2.81e-05	0.000184	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—AKT1—thyroid cancer	2.8e-05	0.000183	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	2.8e-05	0.000183	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	2.79e-05	0.000183	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	2.78e-05	0.000182	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	2.76e-05	0.000181	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—NRAS—thyroid cancer	2.75e-05	0.00018	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	2.75e-05	0.00018	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTGS2—thyroid cancer	2.69e-05	0.000176	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	2.69e-05	0.000176	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	2.68e-05	0.000176	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	2.67e-05	0.000175	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	2.67e-05	0.000175	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	2.63e-05	0.000172	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	2.6e-05	0.00017	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—NRAS—thyroid cancer	2.59e-05	0.00017	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	2.59e-05	0.00017	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	2.59e-05	0.000169	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	2.58e-05	0.000169	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—KRAS—thyroid cancer	2.57e-05	0.000168	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—NRAS—thyroid cancer	2.56e-05	0.000167	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	2.56e-05	0.000167	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	2.56e-05	0.000167	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	2.55e-05	0.000167	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	2.53e-05	0.000165	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—AKT1—thyroid cancer	2.52e-05	0.000165	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—KRAS—thyroid cancer	2.52e-05	0.000165	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	2.51e-05	0.000164	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	2.5e-05	0.000164	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	2.49e-05	0.000163	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—KRAS—thyroid cancer	2.48e-05	0.000162	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	2.47e-05	0.000161	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	2.44e-05	0.00016	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	2.43e-05	0.000159	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	2.43e-05	0.000159	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	2.42e-05	0.000158	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	2.39e-05	0.000156	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	2.38e-05	0.000156	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—KRAS—thyroid cancer	2.37e-05	0.000155	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	2.36e-05	0.000154	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	2.36e-05	0.000154	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTEN—thyroid cancer	2.35e-05	0.000154	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	2.32e-05	0.000152	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	2.32e-05	0.000152	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	2.31e-05	0.000151	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TP53—thyroid cancer	2.29e-05	0.00015	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCND1—thyroid cancer	2.27e-05	0.000149	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TP53—thyroid cancer	2.24e-05	0.000147	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	2.24e-05	0.000146	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—KRAS—thyroid cancer	2.23e-05	0.000146	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	2.23e-05	0.000146	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	2.22e-05	0.000145	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TP53—thyroid cancer	2.2e-05	0.000144	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—KRAS—thyroid cancer	2.2e-05	0.000144	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	2.2e-05	0.000144	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PTEN—thyroid cancer	2.19e-05	0.000144	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—HRAS—thyroid cancer	2.19e-05	0.000143	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	2.17e-05	0.000142	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	2.16e-05	0.000141	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	2.16e-05	0.000141	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—HRAS—thyroid cancer	2.14e-05	0.00014	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	2.14e-05	0.00014	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	2.12e-05	0.000139	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	2.11e-05	0.000138	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—HRAS—thyroid cancer	2.11e-05	0.000138	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	2.11e-05	0.000138	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TP53—thyroid cancer	2.1e-05	0.000138	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	2.04e-05	0.000133	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—HRAS—thyroid cancer	2.01e-05	0.000132	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	1.99e-05	0.00013	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TP53—thyroid cancer	1.98e-05	0.00013	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	1.96e-05	0.000129	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NRAS—thyroid cancer	1.96e-05	0.000128	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TP53—thyroid cancer	1.96e-05	0.000128	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TP53—thyroid cancer	1.96e-05	0.000128	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—AKT1—thyroid cancer	1.93e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	1.93e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	1.92e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	1.92e-05	0.000125	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	1.91e-05	0.000125	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—HRAS—thyroid cancer	1.9e-05	0.000124	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—AKT1—thyroid cancer	1.89e-05	0.000124	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—HRAS—thyroid cancer	1.87e-05	0.000123	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	1.87e-05	0.000123	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—AKT1—thyroid cancer	1.86e-05	0.000122	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	1.86e-05	0.000122	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	1.83e-05	0.00012	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—AKT1—thyroid cancer	1.78e-05	0.000116	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TP53—thyroid cancer	1.77e-05	0.000116	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	1.75e-05	0.000115	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TP53—thyroid cancer	1.71e-05	0.000112	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TP53—thyroid cancer	1.7e-05	0.000111	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	1.69e-05	0.000111	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—KRAS—thyroid cancer	1.69e-05	0.00011	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—AKT1—thyroid cancer	1.68e-05	0.00011	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—AKT1—thyroid cancer	1.67e-05	0.000109	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	1.66e-05	0.000109	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—AKT1—thyroid cancer	1.65e-05	0.000108	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	1.65e-05	0.000108	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TP53—thyroid cancer	1.65e-05	0.000108	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	1.63e-05	0.000107	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TP53—thyroid cancer	1.62e-05	0.000106	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	1.62e-05	0.000106	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	1.58e-05	0.000103	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	1.55e-05	0.000102	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	1.51e-05	9.87e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TP53—thyroid cancer	1.5e-05	9.8e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	1.49e-05	9.77e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TP53—thyroid cancer	1.47e-05	9.65e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	1.44e-05	9.43e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	1.43e-05	9.38e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—HRAS—thyroid cancer	1.43e-05	9.38e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	1.41e-05	9.23e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	1.39e-05	9.12e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	1.37e-05	8.98e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—AKT1—thyroid cancer	1.35e-05	8.86e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	1.34e-05	8.78e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	1.28e-05	8.39e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT1—thyroid cancer	1.26e-05	8.28e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	1.24e-05	8.15e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	1.13e-05	7.41e-05	CbGpPWpGaD
